Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Therapeutics for Biodefense and Emerging Infectious Diseases
Henkel, Timothy
Venatorx Pharmaceuticals, Inc., Malvern, PA, United States
Search 5 grants from Timothy Henkel
Search grants from Venatorx Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
?Regulation of Protein Quality Control by the VCP AAA-ATPase?
Signal transduction in synaptic transmission and plasticity
Functional analysis of the CYLD tumor suppressor
PET Scanner with Time-of-flight Capability using LaBr
Genetics of the Dominantly Inherited Periodic Fever Syndromes
Recently added grants:
Flourine-18 labeled MDM2 antagonists for PET imaging
Multiscale Modeling to Optimize Inhibition of Oncogenic ERK Pathway Signaling
Role of KAT5 in lung cancer
Psychological and brain mechanisms underlying disparities in opioid and non-opioid pain treatment decisions
Single-molecule analysis of eukaryotic transcription activation
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272201600029C-0-0-1
Application #
9358448
Study Section
Project Start
2016-09-23
Project End
2019-01-31
Budget Start
Budget End
Support Year
Fiscal Year
2016
Total Cost
Indirect Cost
Institution
Name
Venatorx Pharmaceuticals, Inc.
Department
Type
DUNS #
962754037
City
Malvern
State
PA
Country
United States
Zip Code
19355
Related projects
Comments
Be the first to comment on Timothy Henkel's grant